NCT05758649Completed
Cardiovascular and Psychological Consequences of COVID-19
Source: ClinicalTrials.gov · Last updated 6 Mar 2024
Brief summary (registry, in English)
The study will assess cardiac and psychological profile at 2-3 months after recovery from COVID-19 infection.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 104 (actual)
- First submitted
- 3 Mar 2023
- Start date
- 1 Oct 2020
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05758649
What you commit to
- Study type: Observational
- Participants enrolled: 104
- From 1 Oct 2020 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Serious clinical conditions (severe chronic inflammatory diseases, neoplasms, neurological pathologies).
Other
- Non-Italian education, illiteracy, or return to illiteracy.
- Severe visual-perceptual deficits.
- Low motivation/interest or refusal to undergo the assessment.
Who the study is looking for
- Recent discharge (≤ 3 months) from a COVID+ ward for SARS-CoV-2 disease
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ICS Maugeri Coordinator of this site? Confirm its status | Pavia | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.